A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α
Xuelei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Hong(University of Suwon)
Cited by 50
Related Papers
Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease
|Annals of Internal Medicine|2007|203